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DNA-release by Streptococcus 
pneumoniae autolysin LytA induced 
Krueppel-like factor 4 expression in 
macrophages
Toni Herta1, Aritra Bhattacharyya1, Christian Bollensdorf1, Christin Kabus1, Pedro García2,3, 
Norbert Suttorp1, Stefan Hippenstiel1 & Janine Zahlten1
The recruitment of myeloid cells to the lung is of utmost importance for the elimination of invading 
pathogens. We investigated the Streptococcus pneumoniae-dependent induction mechanism of KLF4 
in macrophages as a potential regulator of the macrophage immune response. We demonstrated that 
only viable pneumococci, which have direct contact to the host cells and release LytA-dependent DNA, 
induced KLF4. Exogenous supplementation of pneumococcal, other bacterial, eukaryotic foreign 
(human) or self (mouse) DNA to autolysis-deficient pneumococci restored (at least in part) pneumococci-
related KLF4 induction. Experiments using TLR9, TRIF and MyD88 knockout macrophages revealed 
that TLR9, TRIF and MyD88 were partly involved in the S. pneumoniae-induced KLF4 expression. BMMs 
missing important DNA receptor related molecules (ASC−/−, STING−/−) showed no differences in 
pneumococci-related KLF4 expression. Similar results were observed with IFNAR−/− BMMs and Type I 
IFN stimulated cells. LyzMcre mediated knockdown of KLF4 in BMMs resulted in a decreased secretion 
of proinflammatory cytokines and enhanced IL-10 release. In summary, we showed that pneumococci-
related KLF4 induction in macrophages is mediated via a PAMP-DAMP induction mechanism involving a 
hitherto unknown host cell DNA sensor leading to a more proinflammatory macrophage phenotype.
The innate immune response has to be robust, rapid, and highly efficient to kill invading pathogens. During the 
battle between host and pathogen, human cells release numerous mediators, acting on both the invaders and the 
host tissue. If the host response is too weak to eliminate the pathogens, then the risk of systemic spread of bacteria 
with life threatening septicemia increases. On the other hand, in concert with the release of pathogen products 
(e.g. bacterial toxins like pneumococcal pneumolysin1) proinflammatory and toxic agents from the host’s immune 
response itself may impair tissue function. Thus, the innate immune response must not only be able to kill the 
pathogens but also has to be tightly controlled. This delicate balance is highlighted particularly in pneumonia, 
which is one of the major causes of death worldwide. Streptococcus (S.) pneumoniae is the most common source 
of community acquired pneumonia (CAP) across all severities2.
Initially, pneumococci like other bacteria are recognized by different receptors of the innate immune sys-
tem, so-called pattern recognition receptors (PRRs). The PRRs include transmembrane Toll-like receptors 
(TLRs), cytosolic Nod-like receptors (NLRs), RIG-I-like receptors (RLRs) and various cytosolic DNA sensors3. 
Pneumococcal cell wall components such as (lipo)teichoic acids, lipoproteins and peptidoglycan fragments are 
recognized mainly by TLR24,5 and NOD26. Pneumolysin (Ply) activates the inflammasome-forming protein 
NLRP37,8 and was described to be a ligand for TLR49. Apart from TLR9 which detects unmethylated CpG motifs 
found in bacterial DNA10, there are other cytosolic DNA sensors which have been described to potentially recog-
nize not only bacterial DNA but also DNA from foreign vertebrates or self-DNA11. Those potential DNA sensors 
include AIM2 that induces inflammasome formation, DHX9 which seems to regulate NF-κB-dependent gene 
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expression and some others (DAI/ZBP, RNA polymerase III, LRRFIP1; IFI16, DHX36, DDX41) which control 
the production of type I interferons (IFN)11,12. For signal transduction, DNA sensors use the common adapter 
proteins STING (stimulator of interferon genes), ASC (apoptosis-associated speck-like protein containing a card) 
or MyD88 (myeloid differentiation primary response gene 88)11,13. Released type I IFN is recognized via the 
IFNα/β receptor (IFNAR), mediates the expression of IFN-regulated genes (IRGs) and inhibits the induction of 
proinflammatory cytokines such as KC14,15.
S. pneumoniae expresses five cell wall hydrolases. Autolysin (Lyt) A is the main autolysin and is together with 
LytC responsible for the release of e.g. Ply, bacterial DNA and RNA16,17. The release of these factors directly con-
tribute to host tissue damage18 and leads to the PRR-related signaling in the host innate immune response. The 
ligand binding to PRRs and the subsequent activation of signaling cascades cause a strong chemo- and cytokine 
release by pneumococci-infected lung cells5,10,19. The consequence is, among others, a massive recruitment of 
PMNs to the infected lung.
Krueppel-like transcription factors (KLFs) form a subclass of about 17 zinc finger containing DNA-binding 
transcription factors expressed in humans and belong to the specificity protein 1 (Sp1)/KLF zinc finger binding 
transcription factor family20–22. KLF4 was first identified as a critical factor for the establishment of the skin bar-
rier23 and is expressed in different cell types such as endothelial, epithelial and myeloid cells24–27. Recent studies 
indicate an important role of KLF4 for differentiation and activation of myeloid cells24,26,28,29. KLF4 contains an 
activation domain as well as a repression domain21 and is therefore able to induce and suppress the transcrip-
tion of different genes including molecules involved in the regulation of the immune response (e.g. IL-6, IL-8, 
IL-10, MCP-125,27,30). However, in macrophages the function of KLF4 is controversially discussed: Some pub-
lications described a pro-24,28 and others an antiinflammatory KLF4 dependent phenotype26,31. We previously 
found that pneumococcal LytA-related release of bacterial DNA and the recognition by TLR9 induced KLF4 
expression in human lung epithelial cells. KLF4 expression counteracted S. pneumoniae-related NF-κB activation 
and inflammatory IL-8 secretion and induced anti-inflammatory IL-1027,32. In this study, we focused on the S. 
pneumoniae-dependent induction mechanism of KLF4 in macrophages and the possible influence of KLF4 on the 
macrophage inflammatory cytokine response during a pneumococcal infection.
Results
Pneumococci-induced expression of KLF4 in wt BMMs does depend on the bacterial capsule 
but not on phagocytosis. In unstimulated wildtype bone marrow derived macrophages (wt BMMs) no 
expression of KLF4 was detectable (Fig. 1a–c and full-length blots Supplementary Fig. S1). Stimulation of wt 
BMMs for 6 h with the unencapsulated S. pneumoniae mutant strain R6x induced expression of KLF4 on protein 
(Fig. 1a,b) and RNA levels (Fig. 1c). Next, we compared KLF4 expression between the unencapsulated mutants 
R6x and D39∆cps and the encapsulated parent wt strain D39. We found a slightly lower KLF4 expression in 
wt BMMs using the encapsulated pneumococci wt strain D39 compared to the unencapsulated mutants R6x 
and D39∆cps (Fig. 1d,e and full-length blot Supplementary Fig. S1). The capsule of pneumococci is described, 
among other important functions, to prevent S. pneumoniae against phagocytosis33. To unveil a potential role of 
phagocytosis for the pneumococci-induced KLF4 expression we used Cytochalasin D (CytoD) to block phago-
cytic activity of the BMMs. Supplementary Figure S2 shows the input control of the CFU assay (supernatant 
plus cell lysates without gentamycin treatment) which was approximately 7.5 × 105 CFU/ml. No colonies were 
found in the supernatants after gentamycin treatment. About 4 × 105 CFU/ml phagocytosed S. pneumoniae were 
found in the cell lysates without CytoD in contrast to 0 intracellular (IC) pneumococci in the CytoD pretreated 
BMMs (Supplementary Fig. S2). Surprisingly, there were no differences in S. pneumoniae-related KLF4 expres-
sion between CytoD treated and untreated BMMs (Fig. 1f,g and full-length blot Supplementary Fig. S1). Same 
results were obtained using the endocytosis inhibitors filipin III (5 µg/ml), L-methyl β-cyclodextrin (10 mM) and 
chlorpromazine hydrochloride (14 µM) or the phagocytosis inhibitor bafilomycin A1 (25 nM) (Fig. 1h,i and full-
length blot Supplementary Fig. S1).
Pneumococci-induced KLF4 expression in BMMs is only partly mediated by TLR9, TRIF 
and MyD88. Because we and others previously demonstrated that KLF4 expression could be induced by 
TLR-dependent pathways in different cell types24,26,27,34, we stimulated MyD88-, TRIF-, TLR2,3,4,7,9- and 
TLR9-deficient BMMs with 106 CFU/ml R6x and LPS or CpG for 6 h. Neither TLR-related adapter protein 
nor TLR2,3,4,7,9-deficiency abolished S. pneumoniae-induced KLF4 expression (Fig. 2a–h and full-length 
blots Supplementary Fig. S3). In MyD88−/−, TRIF−/− and TLR9−/− BMMs the KLF4 expression seemed to be 
reduced (around 25% compared to wt BMM) but not completely blocked compared to the pneumococci-induced 
KLF4 expression in wt BMMs (Fig. 2a–d and g,h). To crosscheck these results wt BMMs were stimulated with 
LPS, MALP-2 or CpG (Fig. 3a,b and full-length blot Supplementary Fig. S4) solely or as a mixture of different 
pneumococci-related PRR ligands (PRRL mix contains LPS, MALP-2, MDP and CpG) (Supplementary Fig. S5 
and full-length blot Supplementary Fig. S6). Neither the stimulation with the PRRLs alone nor the PRRLs mix-
ture were able to induce KLF4 expression in wt BMMs. Because Ply is potentially recognized by TLR4 and the 
initiated response may differ from LPS/TLR4 signaling, wt BMMs were stimulated with either R6x or R6xΔply 
for 6 h. In line with the stimulation of wt BMMs with LPS we did not observe any differences between Ply com-
petent and Ply-deficient pneumococci in their ability to induce KLF4 expression (Fig. 3c,d and full-length blot 
Supplementary Fig. S4). Since NOD2 also recognizes pneumococci, NOD2-deficient BMMs were stimulated 
with 106 CFU/ml R6x and 100 ng/ml MDP for 6 h and analysed for KLF4. Likewise, we found no influence of 
NOD2 receptor-related signaling concerning S. pneumoniae-induced KLF4 expression (Supplementary Fig. S5 
and full-length blot Supplementary Fig. S6).
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S. pneumoniae viability, replication, autolysis and direct contact to host cells is needed for 
KLF4 induction in BMMs. To further investigate the KLF4-inducing factor of S. pneumoniae in BMMs, 
bacteria were treated differentially to destroy specific components (hi = heat inactivation or PK = Proteinase K 
or PE = Pronase E for protein digestion; eth = ethanol for lipid dissolution; NaIO4 for carbohydrate destruc-
tion). After treatment, bacteria were plated on blood agar plates to prove viability. Only heat inactivation and 
ethanol killed the bacteria, whereas all others were still able to form colonies. Only viable (NaIO4-, Proteinase 
K- and Pronase E-treated) but not dead pneumococci (ethanol- and heat-inactivated) were able to induce KLF4 
expression regardless of the denaturized component (Fig. 4a,b with full-length blot Supplementary Fig. S7 and 
Supplementary Fig. S8 with full-length blot Supplementary Fig. S9), we further tested whether only the presence 
of viable bacteria was needed for KLF4 induction or if bacterial replication was required. To examine the need 
for replication we stimulated wt BMMs in RPMI medium with or without FCS because FCS is necessary for 
Figure 1. Pneumococci induce KLF4 expression in macrophages. Wild type (wt) BMMs were infected with 
106 CFU/ml R6x (a,c) or R6x, D39∆cps and D39 (106 CFU/ml each) (d). Before stimulation with 106 CFU/ml 
R6x wt BMMs were treated with different phagocytosis or endocytosis inhibitors dissolved in DMSO (f,h). 
Cytochalasin D (CytoD) (f), chlorpromazin hydrochloride (CP), filipin III (Fil III), L-methyl β-cyclodextrin 
(MBCD) and bafilomycin A1 (BafA1) (h). Cells were treated with DMSO only for 1 hour to rule out DMSO 
effects (h). Cell lysates were collected after 6 h and analysed for KLF4 expression and actin for equal protein 
load. (a) Shows one representative blot out of 4, (d), (f) and (h) out of 3 independent experiments with 
similar results. The densitometry of the KLF4 and actin bands of the blots was quantified using Odyssey 2.0 
infrared imaging system. The ratio between the KLF4 and actin densitometry was calculated. (b) Shows the 
quantification of the blots of experiment (a), (e) for (d), (g) for (f) and (i) for (h). Data represents mean of 4 (b) 
or 3 (e,g,i) independent experiments. KLF4 RNA was quantified using qPCR (c). Data represents mean ± SEM 
of 3 independent experiments. Differences were indicated as follows: *p < 0.05; **p < 0.01.
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pneumococcal replication (Supplementary Fig. S8). Non-replicating S. pneumoniae were not able to induce KLF4 
expression compared to wt BMMs stimulated with pneumococci in FCS supplemented RPMI (Fig. 4c,d with 
full-length blot Supplementary Fig. S7 and Supplementary Fig. S8 with full-length blot Supplementary Fig. S9). 
Next, we separated pneumococci from wt BMMs using a transwell system and analysed the BMM cell lysates for 
KLF4 expression 6 h after stimulation. As shown in Fig. 4e,f, separation of S. pneumoniae from macrophages abol-
ished pneumococci-induced KLF4 expression while phosphorylated p38 (pp38) mitogen-activated protein kinase 
Figure 2. Pneumococci-induced KLF4 expression is partly mediated by TLR9, MyD88 and TRIF. MyD88- (a), 
TRIF- (c), TLR2,3,4,7,9- (e) and TLR9- (g) knockout BMMs were stimulated with 106 CFU/ml R6x and 100 
ng/ml LPS (a,c) or 1 µg/ml CpG (g). Cell lysates were collected after 6 h and analysed for KLF4 expression and 
actin for equal protein load. All blots show one representative blot out of 3 independent experiments with 
similar results. The densitometry of the KLF4 and actin bands of the blots was quantified using Odyssey 2.0 
infrared imaging system. The ratio between the KLF4 and actin densitometry was calculated. (b) shows the 
quantification of the blots of experiment (a), (d) for (c), (f) for (e) and (h) for (g). Data represents mean of 3 
independent experiments. Differences were indicated as follows: *p < 0.05; ***p < 0.001.
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(MAPK) was still detectable (Fig. 4e,f and full-length blot Supplementary Fig. S7). Given that replicating pneu-
mococci undergo autolysis we used unencapsulated pneumococci deficient for the main autolysin LytA, which 
completely abolished pneumococci-induced KLF4 expression (Fig. 4g,h and full-length blot Supplementary 
Fig. S7).
Supplementation of extracellular DNA restored KLF4 induction by LytA-deficient pneumo-
cocci. Since the LytA-deficient S. pneumoniae mutant strain failed to induce pneumococci-related KLF4 
induction we hypothesized that the KLF4 inducing factor is released by pneumococcal autolysis. To test this 
hypothesis we stimulated wt BMMs with R6x-derived supernatants solely or in combination with R6xΔlytA. As 
shown in Fig. 5a,b, neither the supernatants alone nor the stimulation with LytA-deficient pneumococci induced 
KLF4 expression. Noteworthy was that supplementation of pneumococcal supernatants to LytA-deficient S. pneu-
moniae restored (at least in part) KLF4 induction (Fig. 5a,b and full-length blot Supplementary Fig. S10). As 
one of the components released by bacterial autolysis is bacterial DNA and as it was shown in this study that 
bacterial DNA-recognizing TLR9 is partly involved in the KLF4 induction, we isolated pneumococcal DNA and 
stimulated wt BMMs with the LytA-deficient mutant strain in combination with pneumococcal DNA. Again, 
LytA-deficient pneumococci alone were not able to induce KLF4 expression but in combination with pneumo-
coccal DNA KLF4 expression was restored (Fig. 5c,d and full-length blot Supplementary Fig. S10). Notably, 
KLF4 induction was significantly reduced when pneumococcal DNA was pretreated with DNase before stim-
ulation (Fig. 5e,f and full-length blot Supplementary Fig. S10). Next, we stimulated wt BMMs with R6xΔlytA 
in combination with purified DNA from other bacteria (Escherichia (E.) coli, Staphylococcus (S.) aureus) and 
purified eukaryotic DNA (mouse and human). As expected, KLF4 induction in wt BMMs was (at least partly) 
restored when costimulated with other bacterial DNA, but strikingly eukaryotic DNA was also able to induce 
KLF4 expression in combination with the LytA-deficient pneumococcal mutant strain (Fig. 5g,h and full-length 
blot Supplementary Fig. S10). In contrast, costimulation with pneumococcal RNA was not able to induce KLF4 
expression in wt BMMs (Supplementary Fig. S11 and full-length blot Supplementary Fig. S12). Since TLR9 usu-
ally recognizes prokaryotic DNA, we hypothesized that one of the recently discovered cytosolic DNA sensors 
may participate in pneumococci-dependent KLF4 expression. Therefore, we stimulated DNA sensor-related 
adapter protein-deficient BMMs (ASC−/− and STING−/− BMMs) with R6x. However, neither ASC−/− nor 
STING−/− BMMs displayed a significant difference in KLF4 expression compared to corresponding wt BMMs 
(Supplementary Fig. S11 and full-length blots Supplementary Fig. S12). As induction of KLF4 does not seem to be 
depend on cytosolic DNA sensors we repeated the costimulation of wt BMMS with R6xΔlytA and pneumococcal 
DNA after CytoD pretreatment to block phagocytosis. Interestingly, in line with Fig. 1f,g blocking of phagocytosis 
did not alter KLF4 induction (Fig. 5i,j and full-length blot Supplementary Fig. S10).
Pneumococci-related KLF4 expression does not depend on auto-/paracrine loop of the type I 
IFN response. Because activation of TLR9 and DNA sensors led to a forced type I interferon (IFN) release in 
Figure 3. Pneumococci-induced KLF4 expression is not induced by TLR ligands or pneumolysin (ply). Wt 
BMMs were stimulated with 106 CFU/ml R6x, 100 ng LPS (TLR4 ligand), 100 ng/ml MALP-2 (TLR2 ligand) 
or 1 µg/ml CpG (TLR9 ligand) (a) or with either 106 CFU/ml R6x or 106 CFU/ml R6xΔply (c). Cell lysates 
were collected after 6 h and analysed for KLF4 expression and actin for equal protein load. All blots are 
representatives out of 3 independent experiments with similar results. The densitometry of the KLF4 and actin 
bands of the blots was quantified using Odyssey 2.0 infrared imaging system. The ratio between the KLF4 and 
actin densitometry was calculated. (b) Shows the quantification of the blots of experiment (a) and (d) for (c). 
Data represents mean of 3 independent experiments. Differences were indicated as follows: ***p < 0.001.
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macrophages35 we used interferon-α/β receptor (IFNAR) knockout BMMs to exclude S. pneumoniae-dependent 
KLF4 induction mediated by an auto-/paracrine type I IFN loop in wt BMMs. As shown in Fig. 6a,b the 
pneumococci-mediated KLF4 expression in IFNAR−/− BMMs was equivalent to the wt BMMs (Fig. 6a,b and 
full-length blot Supplementary Fig. S13). Furthermore, stimulation with either 500 U/ml IFNβ alone or in com-
bination with R6xΔlytA was not able to induce KLF4 expression in wt BMMs (Fig. 6c,d and full-length blot 
Supplementary Fig. S13).
Figure 4. S. pneumoniae-dependent KLF4 expression is induced by viable, replicating bacteria which undergo 
autolysis and are in direct contact to the host cells. Wt BMMs were stimulated with 106 CFU/ml viable (R6x 
and NaIO4-inactivated R6x) or 107 CFU/ml dead (heat- (hi) and ethanol-inactivated (eth) R6x) pneumococci 
(a). The need of bacterial replication was tested by a stimulation of wt BMMs with 106 CFU/ml R6x in RPMI 
with or without 10% FCS (c). Wt BMMs were stimulated with 106 CFU/ml R6x in direct contact or separated 
using a transwell system (e) or with R6x and R6xΔlytA (106 CFU/ml each) (g). Cell lysates were collected 6 h 
after stimulation and analysed for KLF4 expression. Actin was used to confirm equal protein load. pp38 proved 
stimulation efficiency (e). All blots are representatives out of 3 independent experiments with similar results. 
The densitometry of the KLF4 and actin bands of the blots was quantified using Odyssey 2.0 infrared imaging 
system. The ratio between the KLF4 and actin densitometry was calculated. (b) shows the quantification 
of the blots of experiment (a), (d) for (c), (f) for (e) and (h) for (g). Data represents mean of 3 independent 
experiments. Differences were indicated as follows: **p < 0.01; ***p < 0.001.
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Figure 5. KLF4 expression is (partly) restored by addition of extracellular pro- and eukaryotic DNA to 
LytA-deficient S. pneumoniae mutants. Wt BMMs were stimulated with 106 CFU/ml R6x, pneumococci 
free supernatants (SN) from S. pneumoniae R6x overnight cultures and 106 CFU/ml R6xΔlytA solely or in 
combination with R6x SN (a). Next, wt BMMs were exposed to 106 CFU/ml R6x, 106 CFU/ml R6xΔlytA 
alone or in combination with 5 µg/ml, 10 µg/ml and 15 µg/ml purified S. pneumoniae-derived DNA (c). 
Costimulation of wt BMMs with 106 CFU/ml R6xΔlytA and 5 µg/ml pneumococcal DNA was repeated with or 
without DNase pretreatment (e), or in combination with purified E. coli, S. aureus, mouse- or human DNA (g). 
After Cytochalasin D (CytoD) pretreatment wt BMMs were stimulated with 106 CFU/ml R6xΔlytA solely or 
combined with 5 µg/ml, 10 µg/ml and 15 µg/ml purified S. pneumoniae DNA (i). Cell lysates were collected after 
6 h and analysed for KLF4 expression. Actin was used to proof equal protein load. (a) Shows one representative 
blot out of 2, (c) out of 4, (e) and (g) out of 3 and (i) out of 4 independent experiments with similar results. 
The densitometry of the KLF4 and actin bands of the blots was quantified using Odyssey 2.0 infrared imaging 
system. The ratio between the KLF4 and actin densitometry was calculated. (b) shows the quantification of 
the blots of experiment (a), (d) for (c), (h) for (g) and (j) for (i). (f) Shows the quantified reduction of KLF4 
expression after DNase pretreatment. Data represents mean of 2 (b), 3 (f,h) or 4 (d,j) independent experiments. 
Differences were indicated as follows: *p < 0.05; **p < 0.01; ***p < 0.001.
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Loss of KLF4 decreased pneumococci-induced proinflammatory cytokine release and enhanced 
IL-10 secretion. For functional analysis of KLF4 in macrophages exposed to pneumococci we used BMMs 
from C57BL/6 LyzMcre−/−/Klf4loxP/loxP (KLF4+/+) and C57BL/6 LyzMcre+/+/Klf4loxP/loxP (KLF4−/−) mice. S. 
pneumoniae-related IL-1β (Fig. 7a), TNFα (Fig. 7b) and IL-6 (Fig. 7c) secretion was significantly reduced in 
KLF4−/− BMMs, whereas pneumococci-related IL-10 secretion was markedly enhanced in KLF4−/− cells com-
pared to KLF4+/+ cells (Fig. 7d). The knockdown of KLF4 was confirmed by KLF4 western blot analysis and is 
shown in Supplementary Fig. S14 (full-length blot Supplementary Fig. S15).
Discussion
Herein we investigated S. pneumoniae-dependent KLF4 induction in murine macrophages. Application of dif-
ferently inactivated (dead or viable) S. pneumoniae, separation of the bacteria from the BMMs, and suppression 
of phagocytosis revealed that direct contact of viable bacteria to the host cells, independent of phagocytosis, is 
needed to induce KLF4 expression in BMMs. In a previous study, we demonstrated that pneumococci-related 
KLF4 expression in human bronchial-epithelial cells depended on the recognition of pneumococcal DNA by 
TLR9 and the related adapter molecule MyD8827. Experiments using TLR9−/− and MyD88−/− BMMs revealed 
that TLR9 and MyD88 are only partially involved in the pneumococci-related KLF4 expression in BMMs (~25% 
reduction), which already indicated a cell-specific response. Nevertheless, pneumococcal DNA seems to be an 
important trigger for KLF4 expression not only in bronchial-epithelial cells but also in BMMs. Exogenous supple-
mentation of S. pneumoniae DNA to the S. pneumoniae-LytA mutant (which is unable to induce KLF4) restored 
KLF4 induction. The addition of DNase reduced this effect. Noteworthy was that S. pneumoniae DNA could be 
(at least partly) substituted with DNA from other bacterial species as well as with foreign eukaryotic (human) 
and self-DNA (mouse), but not with bacterial RNA. As TLR9 mainly detects prokaryotic DNA and only seemed 
to be partially involved in the induction of KLF4 we hypothesized the participation of an additional host cell 
DNA sensor. For this reason, we examined pneumococci-dependent KLF4 expression in BMMs missing the 
putative DNA receptor-related adapter proteins ASC and STING. However, we did not observe a reduction of 
pneumococci-related KLF4 expression. The activation of TLR9 (and other DNA sensors) induces the secretion 
of type I IFNs which are sensed by IFNAR in an auto-/or paracrine manner and leads to the activation of inter-
feron regulatory factors (IRFs) which induce the expression of interferon regulated genes35. KLF4 was previously 
shown to be induced by IRF8 in monocytes36. Strikingly, S. pneumoniae-dependent KLF4 expression was neither 
influenced by IFNAR knockout nor by the stimulation with IFNβ. Furthermore, phagocytosis/endocytosis of 
DNA was not necessary to induce KLF4 although endosomal TLR9 seems to be involved. Thus, we conclude 
that DNA activates TLR9 in an phagocytosis-endocytosis-independent way to induce KLF4 and the putative 
second DNA-receptor might be located on the BMM surface (discussed later). Overall, the results suggest that 
Figure 6. Pneumococci-dependent KLF4 induction in BMMs is not mediated by type I IFN signaling. WT or 
IFNAR-deficient (IFNAR KO) BMMs were stimulated with 106 CFU/ml R6x (a) and wt BMMs were exposed 
to 500 U/ml IFNβ alone or in combination with 106 CFU/ml R6xΔlytA (c). Cell lysates were collected 6 h after 
stimulation and analysed for KLF4 expression. Actin was used to confirm equal protein load. Both blots show 
one representative result out of 2 independent experiments with similar results. The densitometry of the KLF4 
and actin bands of the blots was quantified using Odyssey 2.0 infrared imaging system. The ratio between the 
KLF4 and actin densitometry was calculated. (b) shows the quantification of the blots of experiment (a) and (d) 
for (c). Data represents mean of 2 independent experiments.
www.nature.com/scientificreports/
9SCIentIfIC RePoRTS |  (2018) 8:5723  | DOI:10.1038/s41598-018-24152-1
the KLF4 expression is, in addition to TLR9, mediated by a hitherto unknown DNA receptor or at least by a DNA 
sensor-related pathway independent of phagocytosis/endocytosis, ASC, STING and type I IFNs which detects 
pro- and eukaryotic DNA molecules. A similar mechanism was described by Yasuda et al. showing a stimulation 
of TNFα production in peritoneal- and RAW264.7 macrophages after recognition of pro- or eukaryotic DNA by 
TLR9 and a not yet known second DNA-receptor37.
Because DNA alone was not sufficient to induce KLF4 expression, we hypothesized that at least a second sig-
nal is needed (direct contact of replicating bacteria). Using TLR2,3,4,7,9−/− BMMs a reduction of KLF4 expres-
sion was seen (most likely due to TLR9−/−). Interestingly, TRIF−/− BMMs also showed a significant reduction 
in KLF4 expression (~25%, similar to TLR9−/− and MyD88−/− BMMs), which may be explained by its recently 
discovered function as an adapter protein for TLR9 signaling38. Although TLR2, TLR4 and NOD2 are clearly 
implicated in the recognition of S. pneumoniae6,9,19,39, stimulation of wt BMMs with MALP-2 (TLR2-ligand), LPS 
(TLR4-ligand) and MDP (NOD2-ligand) alone or in a mixture of different PRR ligands including CpG DNA did 
not induce KLF4. Additionally, we examined the role of Ply which is an important virulence factor of S. pneumo-
niae40–42 that activates host cells, at least possibly in part, via recognition by TLR44,9. Nevertheless, Ply-negative 
pneumococci still caused KLF4 expression. Our observations agree with findings from Liao et al. who demon-
strated that KLF4 is rather down-regulated in LPS treated peritoneal macrophages or BMMs than upregulated31. 
However, there exist conflicting results from other groups who showed that KLF4 is induced by LPS in mac-
rophages24,26. Given that KLF4 has a strong impact on macrophage differentiation28,29 and KLF4 expression in 
leukemia-derived monocytes may differ to monocytes obtained from healthy individuals, these inconsistent data 
may be caused by the use of primary macrophages (this study and31) versus leukemia-derived cell lines from 
humans and mice (THP124 and RAW264.7 cells26). Additionally, different sources of LPS (in this study Salmonella 
(S.) minnesota versus S. typhi24 or E. coli26), concentrations and different exposure times may have had an impact 
on the variety of results from the different studies.
As we found a slightly reduced KLF4 induction using the encapsulated D39 pneumococci, this second signal 
may depend on pneumococcal cell wall associated components which are (at least partly) covered by the capsule. 
Figure 7. Loss of KLF4 decreases pneumococci-induced proinflammatory cytokine response and up-regulates 
antiinflammatory IL-10 secretion in BMMs. BMMs derived from C57BL/6 LyzMcre−/−/Klf4loxP/loxP (KLF4+/+) 
and C57BL/6 LyzMcre+/+/Klf4loxP/loxP (KLF4−/−) mice were stimulated with 106 CFU/ml S. pneumoniae D39 
for 15 h. Supernatants were collected and IL-1β (a), TNFα (b), IL-6 (c) and IL-10 (d) ELISAs were performed. 
Data represents mean ± SEM of 6 independent experiments. Differences were indicated as follows: *p < 0.05; 
**p < 0.01; ***p < 0.001.
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Furthermore, the host cell receptor ought to localize extracellularly because the need of phagocytosis could be 
excluded. Since KLF4 induction seemed not to be mediated via TLR2 or NOD2, this pneumococcal cell wall 
associated molecule is unlikely a peptidoglycan, lipoteichoic acid or a lipoprotein (recognized by TLR2 and/or 
NOD2).
As (eukaryotic) DNA is liberated by damaged tissue it can act as a DAMP (damage-associated molecular 
pattern) indicating danger to the host43. Thus, S. pneumoniae seems to induce KLF4 in BMMs by a PAMP-DAMP 
costimulatory signal (schematically summarized in Fig. 8). What could be the rationale behind this mecha-
nism? To answer this question, we investigated the function of KLF4 in BMMs using BMMs from C57BL/6 
LyzMcre+/+/Klf4loxP/loxP mice. In these mice the knockdown of KLF4 is only induced in mature myeloid cells44. 
However, the knockdown efficiency in our experimental setting did not exceed 40% although Liao et al. showed 
90% knockdown efficiency using a similar model31. In general, deletion efficiency in myeloid-Cre deleting strains 
shows variation influenced by factors such as sex of the parent contributing the Cre allel due to variation in Cre 
expression between testes and ovary45 which could contribute to the efficiency difference. Despite the limited 
KLF4 knockdown efficiency, we found a significant alteration of the pneumococci-dependent cytokine release in 
KLF4−/− macrophages. The release of the proinflammatory cytokines IL-1β, TNFα and IL-6 was downregulated 
in KLF4−/− BMMs compared to KLF4+/+ control cells while the release of the anti-inflammatory cytokine IL-10 
was increased. This falls in line with observations of Feinberg and Kaushik et al. who postulated a proinflam-
matory function of KLF4 in macrophages and monocytic microglial cells24,46. Noteworthy was that this puta-
tive proinflammatory role of KLF4 in macrophages contrasted with results in pulmonary epithelial cells, where 
Figure 8. Schematic representation of identified and excluded signaling pathways. The induction of 
pneumococci-dependent KLF4 expression in BMMs needs direct contact of viable bacteria in combination with 
extracellular pro- or eukaryotic DNA. This induction is partly mediated via TLR9/MyD88/TRIF and a probably 
yet unknown extracellular DNA sensor (a). Although TLR9 seems to be partly involved in the KLF4 expression, 
phagocytosis is not required. We additionally could exclude the participation of the receptors TLR2, TLR4, 
NOD2 and IFNAR, as well as the adapter proteins STING and ASC (b).
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the loss of KLF4 enhanced pneumococci-related proinflammatory cytokines32 and decreased anti-inflammatory 
IL-10 release27. These findings underscore the cell-specific activation and effects of KLF4.
Assuming a proinflammatory function of KLF4 in BMMs, we speculated about the meaning of the 
PAMP-DAMP induction mechanism. Perhaps the two components act in a synergistic way to mount a sufficient 
immune response as shown for the induction of iNOS in RAW264.7 macrophages by LPS and bacterial DNA47. 
Alternatively, the second component (direct contact of replicating bacteria) possibly prevents an inadequate acti-
vation of the macrophages by DNA alone. The fact that we did not see any induction of KLF4 by one of the 
two components alone favours the second hypothesis. Since every immune response causes collateral damage 
to host tissue strict regulation is needed48. As we ruled out the need for phagocytosis/endocytosis, a potential 
DNA-sensor present on the cell membrane activated by pro- and eukaryotic DNA bears the risk of severe hyper-
inflammation. Perhaps direct contact of bacteria and BMMs renders this otherwise masked DNA-receptor acces-
sible for its ligand. However, as long as the involved receptors are not clearly identified this remains speculative.
The obtained results strengthen the hypothesis that KLF4 might play a role in innate immunity in the lung. 
Interestingly, there seem to be strong differences between the induction and function of pneumococci-related 
KLF4 expression in macrophages compared to human lung epithelial cells. In this study, we showed that 
pneumococci-induced KLF4 expression in BMMs is mediated by a combined induction mechanism involv-
ing pro- or (in part) eukaryotic DNA and direct contact of bacteria and BMMs leading to a more proinflam-
matory macrophage phenotype. Whereas, in bronchial epithelial cells (as shown in previous studies) the 
pneumococci-dependent KLF4 induction is mediated by pneumococcal DNA alone via TLR9 and MyD88 trig-
gering an anti-inflammatory cytokine release27,32. Therefore, it is tempting to speculate that KLF4 might on the 
one hand support the elimination of invading pneumococci by activating proinflammatory pathways in mac-
rophages and on the other hand it might act as an inflammatory brake in the lung epithelium to prevent hyperin-
flammation and tissue-destruction. This hypothesis should be investigated in further studies.
Materials and Methods
Cytochalasin D and Pronase E were purchased from Sigma-Aldrich (Seelze, Germany), ODN M362 (CpG, 
IFNβ and bafilomycin A1 from Invivogen (San Diego, CA, USA), MDP and MALP-2 from Alexis Biochemicals 
(Lörrach, Germany), LPS from S. minnesota from Enzo Life Sciences GmbH (Lörrach, Germany), Proteinase K, 
chlorpromazin hydrochloride, filipin III and L-methyl β-cyclodextrin from Merck (Darmstadt, Germany). All 
other used chemicals were of analytical grade and received from commercial sources.
Bacterial strains and bacterial products. S. pneumoniae serotype 2 strain D39 wt, D39∆cps and R6x 
(unencapsulated mutants of D39), R6xΔply (pneumolysin-deficient mutant of R6x) and R6xΔlytA (autoly-
sin LytA-deficient mutant of R6x) were used and cultured as described previously27. For inactivation of bac-
teria, 50 ml of 109 CFU/ml S. pneumoniae culture were heated for 1 h at 56 °C or treated with 70% ethanol on 
ice. Pneumococci were processed with NaIO4 (1 µg/ml), Proteinase K (1000 µg/ml) or Pronase E (100 µg/ml) 
for 30 min. For the isolation of bacterial, mouse and human DNA pro- and eukaryotic cells were harvested by 
centrifugation and resuspended in TES, lysed and treated with lysozyme, mutanolysine, RNase, Pronase E and 
sarcosyl. DNA was extracted and precipitated with phenol, sodium acetate and 2-propanol. Digestion of DNA 
was performed by overnight incubation of 5 µg isolated DNA with 5 units DNase at 37 °C. RNA isolation was per-
formed using Trizol, chloroform, as well as isopropanol, and for precipitation GlycoBlue was used. Pneumococcal 
supernatant was generated by incubation of 106 CFU/ml R6x in cell culture medium at 37 °C and in 5% CO2 
for 24 h. Before stimulation, pneumococci and bacterial components were centrifuged for 10 min at 1800 × g. 
Subsequently, collected supernatants were cultured on Columbia agar plates overnight to confirm bacterial free 
condition.
CFU assay. The cells were preincubated with 2 µM CytoD for 30 min before stimulation with 106 CFU/ml R6x. 
One hour post-infection the cells were treated with 50 µg/ml gentamycin (genta) for one hour. The supernatants 
(SN) were collected and the cells were lysed with 1% saponin for 10 min. Serial dilutions of the bacterial suspen-
sions were plated on blood agar plates. The colonies were counted after overnight incubation at 37 °C and 5% CO2 
on blood agar plates and CFUs were calculated.
Endocytosis and phagocytosis inhibition. Wt BMMs were treated with 2 µM CytoD or 25 nM BafA1 for 
30 min to block phagocytosis. Endocytosis was inhibited by treating wt BMMs with 14 µM CP for 30 min, 5 µg/ml 
Fil III for 1 h or 10 mM MBCD for 30 min.
KLF4flox/LyzMcre mice. C57BL/6 ERT-Cre+/−/Klf4loxP/loxP mice and C57BL/6 ERT-Cre−/−/Klf4loxP/
loxP mice (Gary K. Owens; Department of Molecular Physiology and Biological Physics, University of Virginia, 
Charlottesville) and B6.129P2-Lyz2tm1(cre) Ifo mice (Charles River, Sulzfeld, Germany) were mated to generate 
C57BL/6 LyzMcre+/+/Klf4loxP/loxP mice (referred as KLF4−/−) and C57BL/6 LyzMCre−/−/Klf4loxP/loxP mice (referred 
as KLF4+/+).
Ethical Statement. Animal housing complied with the Federation of European Laboratory Animal Science 
Association (FELASA) guidelines and recommendations for the care and use of laboratory animals. The animal 
procedures were approved by the local institutional (Charité - Universitätsmedizin Berlin) and governmental 
(Office for Health and Social Affairs Berlin (LAGeSo), approval ID: T0087/15) authorities.
Cell preparation and cell culture. For the isolation of bone marrow cells, mice were anaesthetized with 
Ketamine and Xylazine i.p. (both Rotexmedica, Luitré, France) and exsanguinated via the caudal vena cava. 
BMMs were prepared from femurs and tibiae of wild type- (wt), NOD2−/−, TLR2,3,4,7,9−/−, TLR9−/−, MyD88−/−, 
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TRIF−/−, STING−/−, ASC−/−, IFNAR−/−, KLF4+/+ and KLF4−/− mice that were all on C57BL/6 background. 
BMMs were cultured in RPMI 1640 medium containing 30% L cell supernatant and 20% FCS and replated 1 day 
prior to infection in RPMI 1640 containing 15% L cell supernatant and 10% FCS.
ELISA. Mouse IL-10, IL-6, TNFα and IL-1β liberation in the supernatants were assessed by ELISA 
Ready-SET-Go! (eBioscience; Frankfurt am Main, Germany) following manufacturer’s instructions.
Western blots. Cultured cells were stimulated as indicated, washed twice and harvested. For western blot 
analysis cells were lysed in buffer containing NP40, subjected to SDS-PAGE and blotted on Hybond-ECL mem-
brane (GE Healthcare, Munich, Germany). Membranes were exposed to antibodies specific for mouse KLF4 
(GKLF antibody (H-180) rabbit polyclonal IgG, sc-20691), actin, pp38 (all Santa Cruz Biotechnology, Inc., 
Heidelberg, Germany) overnight at 4 °C and subsequently incubated with secondary antibodies (anti-goat or 
anti-rabbit either Cy5.5- or IRDye 800–labeled (Rockland, Limerick, PA, USA)) for 1 h at room temperature. 
Proteins were detected and quantified by using an Odyssey 2.0 infrared imaging system (LI-COR Inc., Bad 
Homburg, Germany). The quantification was performed with strict regard to the methodical requirements as 
previously described49. The results were either presented as fold of stimulated control (Fig. 5f) or as KLF4 induc-
tion percentage of infected control (all other graphs of western blot quantification).
qPCR. Total RNA was isolated by TRIzol reagent (Thermo Fisher Scientific). 1 µg of total RNA was 
used to transcribe cDNA (high-capacity cDNA reverse transcription kit; Life Technologies GmbH). After 
pre-amplification (TaqMan® PreAmp master mix kit) the cDNA was diluted and used for qPCR (TaqMan® 
gene expression master mix and TaqMan® gene expression assays for GAPDH: Mm99999915_gl and KLF4: 
Mm00516104_ml; all reagents were obtained from Life Technologies GmbH, Darmstadt, Germany). The proto-
col was performed according to manufactors instructions. Cycling conditions: 2 min, 50 °C; 10 min, 95 °C and 40 
cycles with 15 sec, 95 °C and 1 min, 60 °C.
Statistics. Statistical analysis was done using Prism 6, GraphPad software (San Diego, U.S.A.). The unpaired 
T-test was used for Figs 1c, 5f, S1c and S14b and the Mann-Whitney U test for Figs 1b and 7. One way ANOVA 
with Bonferroni’s multiple comparison test was used when comparing more than two populations.
Data availability statement. The datasets generated during and/or analysed during the current study are 
available from the corresponding author upon reasonable request.
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